APOE and Alzheimer disease: Gorham et al. reported that mtDNA-CN reduction was slower in AD patients carrying APOE ε2/ε3 alleles, supposing that a better preservation in mtDNA-CN levels might be associated with the endowment of this protective APOE genotype [39].